2 Consumer Staple Stocks with High Dividends Before Earnings

Kimberly-Clark Corp (NYSE:KMB) will unveil its latest earnings on Monday, October 24, 2011. The average estimate of analysts is for net income of $1.26 per share, a rise of 10.5% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.28. Between one and three months ago, the average estimate moved down. It has been unchanged at $1.26 during the last month. For the year, analysts are projecting profit of $4.83 per share, a rise of 3.2% from last year.

The company topped estimates last quarter after missing forecasts the quarter prior. In the second quarter, it reported net income of $1.18 per share against a mean estimate of profit of $1.15 per share. In the first quarter, it missed forecasts by 9 cents. Analysts are projecting a rise of 6.6% in revenue from the year-earlier quarter to $5.31 billion.

Competitors to Watch: The Procter & Gamble Co. (NYSE:PG), Cardinal Health, Inc. (NYSE:CAH), Church & Dwight (NYSE:CHD), Colgate-Palmolive (NYSE:CL), Clorox (NYSE:CLX), Johnson & Johnson (NYSE:JNJ), Zep (NYSE:ZEP) and Avon Products (NYSE:AVP).

Lorillard, Inc. (NYSE:LO) will unveil its latest earnings on Monday, October 24, 2011. The average estimate of analysts is for net income of $2.04 per share, a rise of 12.7% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $2.11. Between one and three months ago, the average estimate moved down. It has been unchanged at $2.04 during the last month. Analysts are projecting profit to rise by 14.5% versus last year to $7.76.

The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 3 cents, reporting profit of $2.05 per share against a mean estimate of net income of $2.02 per share. On average, analysts predict $1.14 billion in revenue this quarter, a rise of 6.5% from the year ago quarter. Analysts are forecasting total revenue of $4.46 billion for the year, a rise of 10.1% from last year’s revenue of $4.05 billion.

Competitors to Watch: Reynolds American, Inc. (NYSE:RAI), Altria Group, Inc. (NYSE:MO), Vector Group Ltd. (NYSE:VGR), Philip Morris Intl. Inc. (NYSE:PM), British American Tobacco (AMEX:BTI), Star Scientific, Inc. (NASDAQ:CIGX), Alliance One Intl., Inc. (NYSE:AOI), and Universal Corporation (NYSE:UVV).